Three Guidance Events in One Week Redraw the Statistical Rulebook
FDA's 25-year-overdue BE statistics overhaul, ICH M11's US adoption, and the MHRA's IMA proposal landed simultaneously — at a moment when none of the institutions delivering them can promise smooth implementation.